| Financial Year |
September 30 2020 |
| Monetary Funds |
2,803,389.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
686,058,478.80 |
| Advances to Suppliers |
214,827,611.18 |
| Other Receivables |
280,541,639.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,126,974.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,199,769.98 |
| Total Current Assets |
1,233,557,863.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
319,374,728.07 |
| Long-term Equity Investment |
95,476,481.18 |
| Investment Properties |
-- |
| Fixed Assetes |
382,501.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
915,320,000.00 |
| Sub-Total of Non-Current Assets |
1,972,854,393.90 |
| Total Assets |
3,206,412,257.37 |
| Short-Term Loans |
990,411,842.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
160,398,677.20 |
| Accounts Received In Advance |
6,776,098.86 |
| Employee Compensation Payable |
27,273,235.78 |
| Taxes Payable |
496,895,565.06 |
| Interest Payable |
112,826,158.36 |
| Dividend Payable |
33,686,924.85 |
| Other payables |
418,218,231.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,099,973,650.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
441,054,922.93 |
| Deferred Income Tax Liabilities |
14,887,423.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
455,942,346.52 |
| Total Liabilities |
2,555,915,996.99 |
| Paid-In Capital(Or Share Stock) |
1,093,097,734.00 |
| Capital Surplus |
3,598,332,458.89 |
| Surplus Reserve |
70,877,943.74 |
| LESS:Treasury Stock |
1,967,993.73 |
| Undistributed Profits |
-4,195,072,287.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
650,496,260.38 |
| Owner's Equity（Stockholder's Equity） |
650,496,260.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,206,412,257.37 |
